3Kattan M, Inoue Y, Giles FJ, et al. Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukaemia [J] .Ann Inter Med , 1996,125: 541.
4Liberato N, Quaglini S, Barosi G. Cost-effectiveness of Interferon-Alfa in chronic myelogenous leukaemia[ J]. Br J Haematol, 1999, 106:1013.
5Sonnenberg FA, Beck JR. Markov models in medical decision making:A practical guide[J]. Med Decis Making, 1993,13:322.
6Sawyers CL, Hochhaus A. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase Ⅱ study[J]. Blood,2002,99(10): 3530.
7Talpaz M, Silver RT. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study[J]. Blood ,2002,99(6): 1928.
8Kantarjian H, Sawyers CN. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia[ J ]. Engl J Med,2002,346(9) :645.
9The Italian Cooperative Study Group On Chronic Myeloid Leukemia.Long-Term Follow-Up of the Italian Trial of Interferon-α versus conventional chemotherapy in chronic lyeloid leukemia [ J ] . Blood, 1998,92(5):1541.
5Warren E,Ward S,Gordois A,et al.Cost-utility analysis of imatinib mesylate for the treatment of chwnic myelogenous leukemia in the chwnic phase[J].Clin Therapeut,2004,26(11):1924-1933.
6Kattan MW,Inoue Y,Giles FJ,et al.Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia[J].Ann Intern Med,1996,125(7):541-548.
7Lee SJ,Anasetti C,Kuntz KM,et al.The costs and cost-effectiveness of unrelated donor bone marrow transplantation for chronic phase chronic myelogenous leukemia[J].Blood,1998,92(11):4047-4052.
8Gordois A,Scuffham P,Warren E,et al.Cost-utility analysis of imatinib mesylate for the treatment of advanced stage chronic myeloid leukemia[J].Bri J Cane,2003,89(4):634-640.
9Anstrom KJ,Reed SD,Allen AS,et al.Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia[J].Cancer,2004,101(11):2584-2592.
10Hurvitz H,Fehrenbacher L,Novotny W,et al.Bevacizumab plus iinotecan,fluoruracil,and leucovorin for metasratic correctal [ J ].Nev Engl J Med,2004,350(23):2 335.
